BOT 0.00% 37.0¢ botanix pharmaceuticals ltd

BOT - Anything but charting, page-3771

  1. 81 Posts.
    lightbulb Created with Sketch. 93
    Some of these studies are in 2022 although with the holiday break, may have been missed so thought I'd post this article here for anyone that wishes to do some reading up on some other studies conducted on the effectiveness of CBD on skin conditions: https://www.projectcbd.org/cbd-thc-cbg-skin-conditions
    It does include some on THC and CBG as well.

    Interestingly, study/review 6 in this article published Dec 2022 "Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases" (https://www.mdpi.com/2073-4409/11/24/4102) showed what receptors in the skin do and how they affect some skin diseases. Citing that they found CB1 and CB2 receptors among others downregulated Psoriasis and Atopic Dermatitis.

    https://hotcopper.com.au/data/attachments/5075/5075336-3c534803450940ed3014fe1dc2d7f039.jpg

    This study also references the influence on acne and sebaceous glands and further notes on dermatitis. The article/study references other studies that are older but an interesting read nonetheless and some may find useful. Sections are below:

    https://hotcopper.com.au/data/attachments/5075/5075371-ad35fd12feecd237051d8a247da01d49.jpg
    https://hotcopper.com.au/data/attachments/5075/5075373-750632c94394c31865dd5cb06bf54214.jpg

    From what I can understand and gather from my limited scientific knowledge, is that it's quite likely and there is a lot of evidence to suggest cannabinoid compounds have the ability to treat numerous non-cancer skin diseases, of which BOT has three key products pipelined in this space.

    Onwards and upwards friends.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.